Rates of hypoglycaemia were low, but slightly higher in those who switched to iGlarLixi for all subgroups. Modest weight gain was seen with iGlarLixi, irrespective of previous GLP-1 RA regimen.#Switching to iGlarLixi improved glycaemic control, regardless of screening HbA1c or previous GLP-1 ...